Squarepoint’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-192,115
Closed -$9.81M 5620
2024
Q4
$9.81M Buy
192,115
+73,915
+63% +$3.63M 0.01% 1168
2024
Q3
$4.87M Sell
118,200
-51,598
-30% -$2.48M 0.01% 1440
2024
Q2
$8.18M Sell
169,798
-50,017
-23% -$2.22M 0.01% 1053
2024
Q1
$10.5M Buy
219,815
+40,884
+23% +$2.18M 0.02% 965
2023
Q4
$11.6M Buy
178,931
+104,017
+139% +$6.26M 0.02% 850
2023
Q3
$4.9M Buy
74,914
+50,588
+208% +$3.18M 0.01% 1197
2023
Q2
$1.41M Sell
24,326
-58,557
-71% -$3.69M ﹤0.01% 1913
2023
Q1
$5.12M Buy
82,883
+14,623
+21% +$877K 0.02% 876
2022
Q4
$4.34M Buy
+68,260
New +$4.95M 0.02% 911
2022
Q3
Sell
-8,352
Closed -$568K 3552
2022
Q2
$568K Sell
8,352
-9,541
-53% -$686K ﹤0.01% 1942
2022
Q1
$1.62M Buy
17,893
+4,586
+34% +$375K 0.01% 1279
2021
Q4
$1.22M Sell
13,307
-9,205
-41% -$789K ﹤0.01% 1565
2021
Q3
$1.83M Buy
22,512
+9,574
+74% +$804K 0.01% 1248
2021
Q2
$1.21M Buy
+12,938
New +$1.25M ﹤0.01% 1499

Other funds holding NARI

Squarepoint's NARI Position: Q1 2025 in Review

Squarepoint sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 192,115 shares — an estimated $9.81M sold.

Squarepoint first reported a position in NARI in Q2 2021 and held it in 14 quarters. The position peaked at $11.6M in Q4 2023. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Squarepoint reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Squarepoint sold 192,115 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $9.81M.
  • Squarepoint first reported a position in Inari Medical, Inc. Common Stock in Q2 2021 and held it in 14 quarters.
  • Squarepoint's Inari Medical, Inc. Common Stock position peaked at $11.6M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Squarepoint's 13F filing for Q1 2025, filed 15 May 2025.